A team of researchers from the Universitat Politècnica de València (UPV) and the French National Centre for Scientific ...
Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...
Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB)Phase 2 SHINE Data Show Dramatic Slowing of ...
For women in their 80s, experiencing increasing sleepiness during the day over a five-year period is associated with double ...
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
A February 27 autopsy of Gene Hackman reveals the 95-year-old Oscar winner died of a combination of “advanced Alzheimer’s ...
Age at menopause may interact with factors related to the health of synapses, or nerve cell connections, to influence the risk of Alzheimer’s disease in women, a study found. Associations between ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental Would you want to know you have Alzheimer’s disease years before symptoms of memory loss and confusion set in? An expert ...
The European Medicines Association (EMA) has upheld its decision to recommend the Alzheimer’s drug lecanemab despite concerns that any clinical benefits are small and there is a risk of brain swelling ...
Reminiscence therapy is a type of therapy for people with Alzheimer's disease and other forms of dementia. This type of therapy encourages a person to recall and share positive memories of the past ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results